Walgreens Boots Alliance, Inc.’s Stock Price Tumbles to $19.54, Reflecting a Sharp 9.91% Drop

Walgreens Boots Alliance, Inc. (WBA)

19.54 USD -2.15 (-9.91%) Volume: 35.99M

Walgreens Boots Alliance, Inc.’s stock price currently stands at 19.54 USD, witnessing a decline of -9.91% in this trading session with a trading volume of 35.99M, reflecting a significant YTD percentage change of -25.16%, indicating a challenging market performance for WBA.

Latest developments on Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance (NASDAQ:WBA) stock price experienced fluctuations today due to a myriad of factors. Following their Q2 2024 earnings call, CEO Tim Wentworth’s praise of the human interface and the company’s mission to achieve provider status for pharmacists drew attention. However, concerns from analysts, a significant $2.7 billion tax claim from the IRS, and a price target cut to $20.00 by Morgan Stanley contributed to a dip in the stock. Despite these challenges, the stock crossed a 5% yield mark and was seen as a significantly undervalued opportunity by some investors. Amid these dynamics, several investment firms adjusted their positions in Walgreens Boots Alliance stock.

Walgreens Boots Alliance, Inc. on Smartkarma

On Smartkarma, an independent investment research network, top analysts have been covering Walgreens Boots Alliance (WBA US). Travis Lundy, a provider on the platform, recently published an insight discussing how companies that are removed from the Dow Jones Industrial Average historically outperform their replacements. Lundy also notes that Walgreens is currently cheaper than its competitor CVS. In another insight, Baptista Research, another provider on Smartkarma, highlights Walgreens’ resilience in a challenging US retail environment and their progress in US Healthcare profitability initiatives. The company’s management is also focusing on strategic moves, such as the launch of “Walgreens Health,” to adapt to changing market trends.

A look at Walgreens Boots Alliance, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

After analyzing the Smartkarma Smart Scores for Walgreens Boots Alliance, it appears that the company has a positive long-term outlook. The company’s overall score is a combination of five factors, with a high score of 5 in the dividend category and a score of 4 in both the value and momentum categories. This indicates that the company is performing well in terms of its financials and stock performance, as well as its ability to provide consistent dividends to its shareholders.

Walgreens Boots Alliance operates a variety of retail drugstores and offers a wide range of prescription and non-prescription drugs, as well as general goods. The company also provides various health services, such as primary and acute care, wellness, pharmacy and disease management services, and health and fitness. With a resilience score of 2, the company may face some challenges in the future, but its strong dividend and value scores, along with its positive momentum, suggest that it has a solid foundation for long-term success.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma